Nebula Research & Development LLC Intra Cellular Therapies, Inc. Transaction History
Nebula Research & Development LLC
- $618 Billion
- Q2 2024
A detailed history of Nebula Research & Development LLC transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 33,672 shares of ITCI stock, worth $3.07 Million. This represents 0.37% of its overall portfolio holdings.
Number of Shares
33,672Holding current value
$3.07 Million% of portfolio
0.37%Shares
4 transactions
Others Institutions Holding ITCI
# of Institutions
402Shares Held
89.5MCall Options Held
301KPut Options Held
277K-
Vanguard Group Inc Valley Forge, PA9.61MShares$877 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.32MShares$577 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY5.29MShares$483 Million0.03% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT3.72MShares$339 Million1.37% of portfolio
-
Avoro Capital Advisors LLC New York, NY3MShares$274 Million2.8% of portfolio
About Intra-Cellular Therapies, Inc.
- Ticker ITCI
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 94,401,696
- Market Cap $8.62B
- Description
- Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...